Cover Image
市場調查報告書

印度的幹細胞市場機會

Opportunities in Indian Stem Cell Market

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 341899
出版日期 內容資訊 英文 60 Pages
訂單完成後即時交付
價格
Back to Top
印度的幹細胞市場機會 Opportunities in Indian Stem Cell Market
出版日期: 2015年10月01日 內容資訊: 英文 60 Pages
簡介

透過實現幹細胞的潛力,幹細胞產業這數年來在印度構築了確實的地位。印度的幹細胞市場,尤其是幹細胞銀行部門順利,預計2014年∼2020年以50%的年複合成長率成長。

本報告提供印度的幹細胞市場相關調查分析、市場潛力與未來的成長機會、主要推動因素與課題、競爭情形、主要企業等相關的系統性資訊。

第1章 分析師的見解

第2章 調查手法

第3章 推動因素

  • 慢性疾病的發病率增加
  • 高齡人口的增加
  • 政府的配合措施促進市場成長
  • 醫療觀光的高漲

第4章 課題

  • 認識不足
  • 充分的法規的缺乏
  • 高成本的幹細胞治療、銀行

第5章 幹細胞產品

  • 胚胎幹 (ES) 細胞
  • 成體幹細胞
  • 臍帶幹細胞
  • 牙科幹細胞

第6章 幹細胞的應用

  • 再生醫療
  • 醫藥品開發

第7章 幹細胞產業預測

  • 幹細胞銀行
  • 幹細胞研究

第8章 政府的法規

第9章 最近的發展趨勢

第10章 競爭情形

  • Reliance Life Sciences
  • LifeCell International Private Limited
  • Cryobanks International India Private Limited
  • Cryo-Save (India) Private Limited
  • Cordlife India
  • StemCyte India Therapeutics Private Limited
  • ReeLabs Private Limited
  • Stempeutics Research Private Limited
  • Regenerative Medical Services Private Limited
  • International Stemcell Services Limited

圖表

目錄

Realizing the potential of stem cells, the stem cell industry has been gaining ground in India over the past few years. Although, the market is still in a very nascent stage as compared to developed economies, like the US and Europe, it is expected to grow rapidly in the coming years. The stem cell market in India is mainly concentrated with companies offering stem cell banking facilities, and a very few players are involved in the commercialization of stem cell based products.

With intensive R&D efforts and increasing investments from both government and private organizations in stem cell research, stem cell therapy is expected to emerge as the new elixir for the treatment of various degenerative diseases. Moreover, the liberal regulations governing the stem cell market in India can be an important factor for attracting an increasing number of organizations to invest, create and commercialize promising technologies, thus driving further growth in the market.

According to our research report, "Opportunities in Indian Stem Cell Market", India has the potential to become one of the fastest growing stem cell markets in the world, mainly owing to Stem Cell Banking segment, which is anticipated to grow at a CAGR of around 50% during 2014-2020. With a large number of clinical trials underway, the field of stem cell biology is likely to move towards translational research, and eventually to clinical practice in India.

Our report has been authored to evaluate the Indian Stem Cell Market in terms of Stem Cell Banking and Stem Cell Research, so as to identify the market potential and future growth opportunities. It provides extensive research and analysis of the drivers responsible for the growth of this market, as well as the challenges being faced by the industry.

The report also provides an insight into the recent developments that have taken place in the industry. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities and potentials in the nascent Indian stem cell market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Drivers

  • 3.1 Rising Incidences of Chronic Diseases
  • 3.2 Increasing Aging Population
  • 3.3 Government Initiatives Accelerating Market Growth
  • 3.4 Growing Medical Tourism

4. Challenges

  • 4.1 Lack of Awareness
  • 4.2 Lack of Sufficient Regulations
  • 4.3 High Cost of Stem Cell Therapy and Banking

5. Stem Cell Products

  • 5.1 Embryonic Stem Cells
  • 5.2 Adult Stem Cells
  • 5.3 Umbilical Cord Stem Cells
  • 5.4 Dental Stem Cells

6. Stem Cell Applications

  • 6.1 Regenerative Medicine
  • 6.2 Drug Development

7. Stem Cell Industry Outlook

  • 7.1 Stem Cell Banking
  • 7.2 Stem Cell Research

8. Government Regulations

9. Recent Developments

10. Competitive Landscape

  • 10.1 Reliance Life Sciences
  • 10.2 LifeCell International Private Limited
  • 10.3 Cryobanks International India Private Limited
  • 10.4 Cryo-Save (India) Private Limited
  • 10.5 Cordlife India
  • 10.6 StemCyte India Therapeutics Private Limited
  • 10.7 ReeLabs Private Limited
  • 10.8 Stempeutics Research Private Limited
  • 10.9 Regenerative Medical Services Private Limited
  • 10.10 International Stemcell Services Limited

List of Figures:

  • Figure 3-1: India - Relative Burden of Chronic Conditions (2015)
  • Figure 3-2: India - Population Aged 60 and Above (Million), 2014 & 2050
  • Figure 3-3: India - Medical Tourism Market (Billion US$), 2014-2020
  • Figure 7-1: India - Stem Cell Banking Market (Million US$), 2014-2020

List of Tables:

  • Table 7-1: Stem Cell Clinical Trials Registered in Clinical Trials Registry - India (CTRI)
  • Table 10-1: Reliance Life Sciences - Stem Cell Products Offered
  • Table 10-2: Reliance Life Sciences - Programs Offered Under Cord Blood Repository Services
  • Table 10-3: LifeCell International Pvt. Ltd. - Umbilical Cord Stem Cell Banking Plans and Price
  • Table 10-4: Cryo-Save (India) Pvt. Ltd. - Umbilical Cord Blood Banking Price
  • Table 10-5: Cordlife India - Umbilical Cord Stem Cell Banking Plans and Price (21 Years Storage)
  • Table 10-6: Regenerative Medical Services Pvt. Ltd. - Stem Cell Therapy Products
Back to Top